1
|
Singhal S, Jairam MP, Jhala K, Hammer MM. Abnormal Gas at Chest Radiography: A Primer with CT and 3D Reconstruction Correlation. Radiographics 2024; 44:e230146. [PMID: 38386599 DOI: 10.1148/rg.230146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2024]
Affiliation(s)
- Sameer Singhal
- From the Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115
| | - Meghan P Jairam
- From the Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115
| | - Khushboo Jhala
- From the Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115
| | - Mark M Hammer
- From the Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115
| |
Collapse
|
2
|
Liu B, Grindrod N, Meyers BM, Freiburger S, Boldt G, Malik A, Jairam MP, Brahmania M, Cardarelli Leite L, Simone CB, Chow R, Lock M. Treatment modalities to manage hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and meta-analysis. Ann Palliat Med 2023; 12:1165-1174. [PMID: 37953217 DOI: 10.21037/apm-23-463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Accepted: 10/09/2023] [Indexed: 11/14/2023]
Abstract
BACKGROUND A number of therapeutic treatment strategies exist for patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT). The aim of this review is to provide a current understanding of treatment options and determine the relative effectiveness of treatment options in preventing mortality over 24 months. METHODS A search was conducted in PubMed, EMBASE and Cochrane CENTRAL from 2007 to 2022. Articles were screened to identify those that reported on all-cause mortality among treated, non-palliative patients with HCC and PVT. Study quality was assessed using the Cochrane Risk of Bias in Non-Randomized Studies of Interventions tool (ROBINS-1). Mortality rates at prespecified timepoints between 6 and 24 months were extracted and summarized using a random-effects DerSimonian-Laird model. This review was registered a priori on PROSPERO (CRD42022290708). RESULTS When comparing radiotherapy (RT) to sorafenib and combined transarterial chemoembolization (TACE), there was a trend that RT yields better survival at 6 months [odds ratio (OR) 0.70, 95% confidence interval (CI): 0.28-1.76]. When comparing sorafenib to Y90 and RT, sorafenib was associated with higher odds for mortality at 6 months (OR 2.20, 95% CI: 1.11-4.39). No significant differences were noticed from 12 to 24 months. CONCLUSIONS Future strategies for HCC with PVT should look at the combination of radiation and systemic treatments either concurrently or sequentially.
Collapse
Affiliation(s)
- Brandon Liu
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
| | - Natalie Grindrod
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
| | - Brandon M Meyers
- Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
| | - Sarah Freiburger
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
| | - Gabriel Boldt
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
| | - Aleena Malik
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
| | - Meghan P Jairam
- Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, MA, USA
| | - Mayur Brahmania
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
| | - Leandro Cardarelli Leite
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
| | - Charles B Simone
- New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Ronald Chow
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Michael Lock
- London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
| |
Collapse
|
3
|
Malik A, Jairam MP, Chow R, Mirshahvalad SA, Veit-Haibach P, Simone CB. Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma. Future Oncol 2023; 19:277-278. [PMID: 36916468 DOI: 10.2217/fon-2022-0713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
Affiliation(s)
- Aleena Malik
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
| | - Meghan P Jairam
- Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Ronald Chow
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.,New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | | | - Charles B Simone
- New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| |
Collapse
|
4
|
Malik A, Jairam MP, Chow R, Mirshahvalad SA, Veit-Haibach P, Simone CB. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression. Future Oncol 2023; 19:279-287. [PMID: 36916490 PMCID: PMC10135443 DOI: 10.2217/fon-2022-0893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Accepted: 01/31/2023] [Indexed: 03/15/2023] Open
Abstract
Aim: The aim of this meta-regression was to assess the impact of mean/median age, mean/median tumor size, percentage of males in total sample, and total sample size on the comparative effectiveness of radiofrequency ablation (RFA) and stereotactic body radiation therapy (SBRT). Methods: Ten studies reporting on the composite outcome of overall survival and local control were included. Results: A significant relationship was found between age and overall survival at 1 and 2 for both RFA and SBRT. A significant relationship was noted also between age and local control at 1 and 2 years for RFA. Conclusion: Patients treated with SBRT had a wider range of tumor sizes and larger tumor sizes; no relationship was observed between tumor size and overall survival or local control by SBRT.
Collapse
Affiliation(s)
- Aleena Malik
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
| | - Meghan P Jairam
- Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Ronald Chow
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | | | - Charles B Simone
- New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| |
Collapse
|
5
|
Chiu L, Jairam MP, Chow R, Chiu N, Shen M, Alhassan A, Lo CH, Chen A, Kennel PJ, Poterucha TJ, Topkara VK. Erratum to 'Meta-Analysis of Point-of-Care Lung Ultrasonography Versus Chest Radiography in Adults With Symptoms of Acute Decompensated Heart Failure' The American Journal of Cardiology Volume 174, 1 July 2022, Pages 89-95. Am J Cardiol 2022; 180:173. [PMID: 36064260 DOI: 10.1016/j.amjcard.2022.08.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Leonard Chiu
- Vanderbilt University Medical Center, Vanderbilt University School of Medicine, Vanderbilt University, Nashville, Tennessee
| | | | - Ronald Chow
- Temerity Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Nicholas Chiu
- Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts
| | - Max Shen
- Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts
| | - Adam Alhassan
- University of Pittsburgh Medical Center, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Chun-Han Lo
- Massachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts
| | - Austin Chen
- Columbia University, Vagelos College of Physicians and Surgeons, Columbia University, Department of Medicine, New York, NY
| | - Peter J Kennel
- New York Presbyterian Hospital/Columbia University Irving Medical Center, Columbia University, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York
| | - Timothy J Poterucha
- New York Presbyterian Hospital/Columbia University Irving Medical Center, Columbia University, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York
| | - Veli K Topkara
- New York Presbyterian Hospital/Columbia University Irving Medical Center, Columbia University, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
| |
Collapse
|
6
|
Chiu L, Jairam MP, Chow R, Chiu N, Shen M, Alhassan A, Lo CH, Chen A, Kennel PJ, Poterucha TJ, Topkara VK. Meta-Analysis of Point-of-Care Lung Ultrasonography Versus Chest Radiography in Adults With Symptoms of Acute Decompensated Heart Failure. Am J Cardiol 2022; 174:89-95. [PMID: 35504747 DOI: 10.1016/j.amjcard.2022.03.022] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 03/09/2022] [Accepted: 03/15/2022] [Indexed: 12/26/2022]
Abstract
Acute decompensated heart failure (ADHF) is a primary cause of older adults presenting to the emergency department with acute dyspnea. Point-of-care lung ultrasound (LUS) has shown comparable or superior diagnostic accuracy in comparison with a chest x-ray (CXR) in patients presenting with symptoms of ADHF. The systematic review and meta-analysis aimed to elucidate the sensitivity and specificity of LUS in comparison with CXR for diagnosing ADHF and summarize the rapidly growing body of evidence in this domain. A total of 5 databases were searched through February 18, 2021, to identify observational studies that reported on the use of LUS compared with CXR in diagnosing ADHF in patients presenting with shortness of breath. Meta-analysis was conducted on the sensitivities and specificities of each diagnostic method. A total of 8 studies reporting on 2,787 patients were included in this meta-analysis. For patients presenting with signs and symptoms of ADHF, LUS was found to be more sensitive than CXR (91.8% vs 76.5%) and more specific than CXR (92.3% vs 87.0%) for the detection of cardiogenic pulmonary edema. In conclusion, LUS is more sensitive and specific than CXR in detecting pulmonary edema. This highlights the importance of sonographic B-lines, along with the accurate interpretation of clinical data, in the diagnosis of ADHF. In addition to its convenience, reduced costs, and reduced radiation exposure, LUS should be considered an effective alternative to CXR for evaluating patients with dyspnea in the setting of ADHF.
Collapse
|
7
|
Ha R, Jairam MP. A review of artificial intelligence in mammography. Clin Imaging 2022; 88:36-44. [DOI: 10.1016/j.clinimag.2022.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Revised: 04/28/2022] [Accepted: 05/12/2022] [Indexed: 11/16/2022]
|
8
|
Abstract
Ocular cicatricial pemphigoid (OCP) represents an insidious, autoimmune-mediated disease of the conjunctiva, initially presenting as chronic conjunctivitis and progressing to fibrosis, cicatrization, and eventually blindness secondary to corneal keratinization. This series reports 3 cases presenting with chronic conjunctivitis lasting an average of 10 years without cicatrix formation, ultimately diagnosed as OCP based on direct immunofluorescence of conjunctival biopsy samples. This chronic conjunctivitis without fibrosis suggests the possibility of an OCP subtype with a prolonged early stage or prodrome prior to cicatrization, which may benefit from early diagnosis and treatment to prevent complications of this disease.
Collapse
Affiliation(s)
- Sonya Besagar
- Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, U.S.A
| | - Ashley O London
- Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, U.S.A
| | - Meghan P Jairam
- Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, U.S.A
| | - Danielle Trief
- Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, U.S.A
| | - Lora R Dagi Glass
- Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, U.S.A
| |
Collapse
|